These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20701719)

  • 21. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial.
    Panchaud A; Sauty A; Kernen Y; Decosterd LA; Buclin T; Boulat O; Hug C; Pilet M; Roulet M
    Clin Nutr; 2006 Jun; 25(3):418-27. PubMed ID: 16325968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary omega-3 fatty acids: effects on lipid mediators of inflammation and rheumatoid arthritis.
    Sperling RI
    Rheum Dis Clin North Am; 1991 May; 17(2):373-89. PubMed ID: 1862246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients.
    Begum R; Belury MA; Burgess JR; Peck LW
    J Ren Nutr; 2004 Oct; 14(4):233-41. PubMed ID: 15483784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of omega-3 fatty acids in cardiovascular disease.
    Saremi A; Arora R
    Am J Ther; 2009; 16(5):421-36. PubMed ID: 19092647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy.
    Biondo PD; Brindley DN; Sawyer MB; Field CJ
    J Nutr Biochem; 2008 Dec; 19(12):787-96. PubMed ID: 18602809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study.
    Griffin BA
    Curr Opin Lipidol; 2008 Feb; 19(1):57-62. PubMed ID: 18196988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations.
    Czernichow S; Thomas D; Bruckert E
    Br J Nutr; 2010 Sep; 104(6):788-96. PubMed ID: 20522273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary fatty acids and cardiovascular disease: an epidemiological approach.
    Erkkilä A; de Mello VD; Risérus U; Laaksonen DE
    Prog Lipid Res; 2008 May; 47(3):172-87. PubMed ID: 18328267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
    Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
    Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health.
    Siddiqui RA; Harvey KA; Zaloga GP
    J Nutr Biochem; 2008 Jul; 19(7):417-37. PubMed ID: 17904342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of omega-3 fatty acids in mood disorders.
    Stahl LA; Begg DP; Weisinger RS; Sinclair AJ
    Curr Opin Investig Drugs; 2008 Jan; 9(1):57-64. PubMed ID: 18183532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
    Ewers B; Riserus U; Marckmann P
    J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases.
    Siener R; Alteheld B; Terjung B; Junghans B; Bitterlich N; Stehle P; Metzner C
    Eur J Clin Nutr; 2010 Apr; 64(4):410-8. PubMed ID: 20160750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
    Verboom CN;
    Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK; Kostkiewicz M
    Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiovascular effects of omega-3-fatty acids and alternatives to increase their intake].
    Carrero JJ; Martín-Bautista E; Baró L; Fonollá J; Jiménez J; Boza JJ; López-Huertas E
    Nutr Hosp; 2005; 20(1):63-9. PubMed ID: 15762422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-3 fatty acids. Current status in cardiovascular medicine.
    Schmidt EB; Dyerberg J
    Drugs; 1994 Mar; 47(3):405-24. PubMed ID: 7514972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary n-3 LC-PUFA during the perinatal period as a strategy to minimize childhood allergic disease.
    Makrides M; Gunaratne AW; Collins CT
    Nestle Nutr Inst Workshop Ser; 2013; 77():155-62. PubMed ID: 24107505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.
    Mozaffarian D; Wu JH
    J Am Coll Cardiol; 2011 Nov; 58(20):2047-67. PubMed ID: 22051327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.